number
econom
evalu
relat
infecti
diseas
topic
gradual
increas
last
decad
databas
search
suggest
may
account
around
literatur
modelbas
econom
evalu
see
figur
appendix
area
rapidli
grow
import
sever
concurr
trend
contribut
expans
despit
larg
reduct
incid
infecti
diseas
last
year
still
second
common
caus
death
worldwid
account
year
million
death
million
lost
disabilityadjust
lifeyear
burden
combin
risk
highprofil
econom
damag
outbreak
ensur
continu
import
public
health
perspect
infecti
diseas
kept
public
conscious
result
emerg
diseas
west
nile
viru
hiv
pandem
sever
acut
respiratori
syndrom
sar
influenza
threat
bioterror
emerg
antimicrobialresist
strain
exist
pathogen
human
econom
impact
emerg
pathogen
difficult
estim
potenti
devast
addit
infecti
aetiolog
discov
number
diseas
hepat
c
e
peptic
ulcer
cervic
cancer
origin
thought
noncommunic
time
advanc
molecular
medicin
facilit
develop
new
tool
prevent
control
infecti
diseas
last
decad
call
new
golden
age
develop
vaccin
effect
intervent
infecti
diseas
main
purchas
vaccin
govern
larg
nongovernment
organ
sinc
effect
use
part
populationlevel
public
health
programm
although
vaccin
tradit
one
costeffect
intervent
avail
high
price
new
vaccin
result
subject
greater
scrutini
includ
pharmacoeconom
evalu
decis
maker
instanc
increas
role
econom
evalu
inform
prioriti
global
initi
global
allianc
vaccin
immunis
gavi
allianc
mathemat
model
offer
public
health
planner
abil
make
predict
impact
emerg
diseas
well
effect
possibl
respons
control
measur
model
need
bridg
gap
clinic
trial
measur
individuallevel
efficaci
short
period
time
highli
select
subpopul
populationlevel
use
particularli
crucial
infecti
diseas
mass
intervent
vaccin
screen
result
effect
popul
level
seen
individu
level
includ
herd
immun
chang
epidemiolog
infect
chang
pathogen
ecolog
consequ
select
pressur
infecti
diseas
model
common
use
epidemiolog
well
develop
set
techniqu
develop
past
decad
model
epidemiolog
impact
intervent
vaccin
sinc
intervent
consum
scarc
healthcar
resourc
decis
maker
increasingli
interest
combin
model
pharmacoeconom
techniqu
order
investig
whether
intervent
provid
good
valu
resourc
invest
howev
despit
expans
appli
literatur
econom
evalu
infecti
diseas
intervent
model
underpin
evalu
alway
use
appropri
mani
econom
evalu
infecti
diseas
intervent
appli
model
take
account
uniqu
complex
infecti
diseas
transmiss
infect
suscept
individu
possibl
acquir
natur
immun
infect
uncertainti
aris
result
complex
natur
histori
epidemiolog
recent
number
health
economist
comment
shortcom
urg
model
adopt
techniqu
well
establish
infecti
diseas
epidemiolog
literatur
recent
systemat
review
econom
model
chlamydia
trachomati
screen
found
almost
inappropri
use
static
model
fail
take
account
onward
transmiss
chlamydia
infect
henc
like
incorrectli
estim
cost
effect
screen
similar
conclus
drawn
review
model
hepat
hepat
b
varicella
meningococc
human
papillomaviru
hpv
vaccin
articl
introduct
basic
type
underli
principl
epidemiolog
model
infecti
diseas
intervent
way
affect
econom
evalu
built
around
model
review
focus
issu
around
model
epidemiolog
infecti
diseas
norm
econom
issu
around
econom
evalu
infecti
diseas
intervent
discuss
extens
elsewher
comprehens
taxonomi
decis
analyt
model
publish
recent
taxonomi
adapt
econom
evalu
vaccin
taxonomi
categor
model
base
whether
state
model
chang
time
dynam
static
ii
chang
model
occur
random
stochast
fix
determinist
iii
model
averag
behaviour
popul
aggreg
track
individu
individu
base
iv
event
occur
discret
continu
time
v
individu
enter
leav
popul
open
close
vi
model
equat
linear
nonlinear
function
paramet
articl
highlight
key
distinct
type
infecti
diseas
model
discuss
detail
previou
review
well
way
model
featur
affect
estim
cost
effect
intervent
key
term
use
review
defin
appendix
indic
ital
first
use
text
infecti
diseas
model
interest
economist
usual
estim
effect
intervent
henc
use
evalu
cost
outcom
rather
simpli
make
predict
unfold
epidem
longterm
trend
incid
endem
diseas
type
intervent
evalu
determin
type
epidemiolog
model
use
captur
key
element
diseas
common
intervent
relat
infecti
diseas
analys
use
econom
model
includ
follow
vaccin
vaccin
one
main
area
applic
pharmacoeconom
model
incorpor
model
infecti
diseas
transmiss
transmiss
model
need
order
captur
inher
nonlinear
effect
vaccin
result
potenti
vaccin
protect
directli
vaccin
individu
also
contact
infecti
diseas
model
use
predict
effect
vaccin
review
elsewher
screen
screen
infect
individu
allow
treat
progress
sever
diseas
andor
infect
individu
model
need
incorpor
transmiss
earli
detect
affect
transmiss
shown
import
mani
infecti
diseas
chlamydia
hiv
model
may
allow
possibl
screen
treat
individu
may
reinfect
would
decreas
cost
effect
screen
social
distanc
plan
respons
larg
outbreak
infecti
diseas
influenza
pandem
often
involv
social
distanc
measur
isol
suspect
case
school
closur
travel
restrict
cancel
mass
gather
footbal
match
may
affect
progress
epidem
come
cost
term
individu
liberti
econom
activ
within
popul
benefit
depend
crucial
frequenc
type
interact
occur
individu
differ
age
group
set
famili
work
place
school
inform
obtain
populationbas
survey
avail
europ
us
smaller
level
model
estim
impact
isol
infecti
individu
outbreak
close
institut
set
hospit
nurs
home
school
postexposur
treatment
chemotreat
option
antimicrobi
dealt
use
static
model
unless
alter
transmiss
individu
transmitt
characterist
infect
model
fall
latter
categori
includ
use
antiretrovir
hiv
increas
life
expect
infect
individu
decreas
infecti
antimicrobi
use
pathogen
develop
resist
antivir
prophylaxi
delay
spread
pandem
influenza
cull
anim
plant
diseas
one
option
interrupt
transmiss
deplet
host
popul
cull
infect
livestock
even
healthi
livestock
risk
infect
model
examin
tradeoff
reduc
infect
transmiss
detriment
death
anim
plant
result
cull
model
appli
epidem
diseas
footandmouth
diseas
avian
influenza
infecti
diseas
communic
caus
agent
directli
transmit
host
host
communic
natur
import
effect
effect
prevent
intervent
risk
acquir
infect
depend
individu
characterist
potenti
host
age
whether
prophylact
intervent
receiv
also
preval
infect
among
peopl
popul
potenti
host
may
come
contact
henc
protect
proport
peopl
popul
becom
infect
nonlinear
effect
remaind
popul
proport
popul
suscept
infect
suffici
low
individu
either
infect
natur
immun
infect
vaccin
protect
infect
individu
transmit
diseas
fewer
one
suscept
person
recov
consequ
preval
infect
decreas
time
herd
immun
decreas
rate
infect
popul
larg
proport
member
immun
henc
reduc
probabl
infect
individu
contact
suscept
individu
proport
popul
need
resist
order
ensur
epidem
spread
infect
individu
transmit
infect
less
one
suscept
person
call
herd
immun
threshold
concept
vital
model
vaccin
programm
sinc
aim
vaccin
protect
larg
enough
proport
popul
elimin
infect
import
implic
way
infecti
diseas
model
evalu
intervent
involv
noncommunic
diseas
common
type
decis
analyt
model
use
health
economist
cohort
model
decis
tree
markov
model
two
main
characterist
first
usual
model
close
popul
individu
allow
enter
popul
time
consist
singl
birth
cohort
second
probabl
individu
move
state
repres
differ
branch
decis
tree
differ
transit
state
markov
model
depend
characterist
individu
number
peopl
infecti
reason
various
call
static
model
model
without
interact
infecti
diseas
usual
appropri
use
transmiss
dynam
model
repres
entir
popul
multipl
birth
cohort
popul
model
usual
open
new
individu
creat
birth
although
model
short
time
scale
may
singl
close
popul
without
birth
furthermor
intervent
one
individu
effect
other
probabl
suscept
individu
move
infecti
state
depend
proport
peopl
suscept
state
also
proport
peopl
infect
state
instantan
rate
suscept
peopl
becom
infect
call
forc
infect
static
model
forc
infect
constant
time
dynam
model
function
proport
popul
infect
henc
chang
time
compar
static
cohort
model
transmiss
dynam
model
usual
analyt
complex
requir
epidemiolog
inform
parameter
demand
comput
resourc
implement
henc
advantag
use
necessari
intervent
potenti
produc
signific
chang
forc
infect
occur
sever
way
intervent
may
decreas
proport
popul
suscept
decreas
proport
popul
infect
decreas
rate
infect
transmit
infect
suscept
peopl
exampl
intervent
vaccin
infant
measl
screen
treat
tuberculosi
carrier
popul
close
school
influenza
pandem
intervent
may
also
caus
chang
characterist
infecti
agent
select
pressur
exampl
includ
emerg
antibacterialresist
strain
bacteria
result
antibacteri
use
increas
preval
certain
strain
bacteria
result
vaccin
strain
econom
model
prevent
intervent
vaccin
screen
social
distanc
compar
intervent
dynam
model
usual
indic
intervent
cost
effect
equival
static
model
occur
two
reason
first
dynam
model
predict
greater
number
infect
prevent
intervent
directli
protect
intervent
predict
static
model
well
indirectli
protect
herd
immun
second
dynam
model
predict
faster
reduct
number
infect
static
model
benefici
econom
model
posit
time
prefer
discuss
case
meningococc
varicella
vaccin
illustr
use
hypothet
infant
vaccin
programm
figur
henc
dynam
model
usual
predict
costeffect
outcom
short
term
due
rapid
effect
also
long
term
effect
herd
immun
accumul
time
consequ
static
model
indic
intervent
cost
effect
dynam
model
usual
show
henc
static
model
may
suffici
obtain
conserv
estim
cost
effect
howev
sever
reason
dynam
model
may
still
necessari
even
static
dynam
model
agre
qualit
predict
favour
cost
effect
intervent
dynam
model
might
predict
complex
realist
time
cours
diseas
incid
would
static
model
one
exampl
dynam
popul
follow
vaccin
level
coverag
insuffici
reduc
number
suscept
herd
immun
threshold
figur
show
dynam
model
predict
vaccin
programm
caus
incid
infect
initi
drop
low
level
time
period
call
honeymoon
period
later
show
sharp
temporari
increas
due
accumul
suscept
individu
period
forc
infect
low
reallif
exampl
outbreak
rubella
greec
follow
year
low
diseas
incid
partial
rubella
vaccin
none
behaviour
shown
static
model
sharp
increas
econom
import
indic
need
retain
spare
healthcar
capac
accommod
futur
spike
demanda
dynam
model
may
show
intervent
caus
chang
profil
infect
individu
seen
static
model
instanc
vaccin
reduc
forc
infect
caus
averag
age
infect
increas
period
cycl
infect
incid
lengthen
econom
import
instanc
vaccin
rubella
low
level
coverag
caus
averag
age
time
rubella
infect
increas
childhood
childbear
age
increas
risk
congenit
rubella
syndrom
condit
caus
born
mother
rubella
pregnanc
dynam
model
may
reveal
relationship
variabl
appar
use
static
model
alon
seen
comparison
static
dynam
model
therapeut
antivir
use
netherland
influenza
pandem
model
predict
intervent
would
cost
effect
howev
dynam
model
suggest
costeffect
ratio
would
sensit
size
pandem
wherea
static
model
show
relationshipwhen
one
prevent
intervent
compar
anoth
dynam
model
necessarili
give
costeffect
result
static
model
sinc
predict
option
greater
effect
predict
static
model
exampl
use
econom
model
determin
appropri
age
catchup
vaccin
campaign
requir
compar
sever
catchup
vaccin
strategi
cover
differ
age
rang
diseas
caus
sever
type
subtyp
organ
intervent
induc
select
pressur
caus
subset
type
gain
fit
advantag
other
exampl
replac
one
type
bacteria
anoth
follow
vaccin
emerg
antimicrobialresist
respiratori
tract
infect
follow
antibacteri
use
dynam
model
incorpor
multipl
bacteria
type
predict
longterm
emerg
behaviour
seen
static
model
model
usual
incorpor
competit
paramet
measur
abil
one
strain
infect
host
alreadi
infect
anoth
strain
hand
dynam
model
unnecessari
intervent
effect
forc
infect
peopl
receiv
intervent
one
case
infect
rabi
west
nile
viru
environment
reservoir
larg
unaffect
proport
infect
peopl
popul
intervent
target
human
host
rather
anim
insect
reservoir
littl
effect
forc
infect
true
intervent
affect
sever
diseas
infect
peopl
transmiss
endoflif
therapi
cervic
cancer
significantli
affect
transmiss
caus
infect
agent
hpv
sinc
occur
decad
develop
cancer
anoth
exampl
vaccin
prevent
individu
get
diseas
infect
prevent
acquir
infect
asymptomat
instanc
earli
econom
model
pneumococc
rotaviru
vaccin
larg
static
known
whether
vaccin
would
prevent
transmiss
simpli
reduc
risk
diseas
recent
howev
evid
emerg
vaccin
may
also
prevent
transmiss
recent
dynam
model
vaccin
incorpor
herd
immun
develop
one
method
use
avoid
complex
dynam
model
retain
static
cohort
model
structur
approxim
popul
effect
intervent
experi
anoth
similar
popul
undergon
intervent
result
dynam
model
use
differ
situat
sever
exampl
econom
evalu
vaccin
static
cohort
model
use
estim
cost
effect
pneumococc
vaccin
england
meningococc
c
vaccin
quebec
extend
use
inform
postvaccin
surveil
us
estim
populationlevel
impact
similarli
indirect
benefit
pertussi
vaccin
estim
cohort
model
pertussi
vaccin
use
equilibrium
valu
separ
dynam
model
besid
evalu
vaccin
costeffect
evalu
hiv
screen
assum
fix
reduct
secondari
case
detect
treat
primari
hiv
case
number
danger
approach
first
requir
use
estim
either
dynam
model
surveil
conduct
differ
popul
situat
sinc
would
unnecessari
use
model
alreadi
good
inform
longterm
effect
intervent
popul
howev
differ
popul
age
profil
like
uptak
intervent
size
age
risk
group
mix
frequenc
individu
popul
may
alter
intervent
effect
unpredict
way
instanc
postmarket
surveil
follow
introduct
pneumococc
vaccin
england
wale
reveal
level
serotyp
replac
seen
us
surveil
data
second
estim
herd
immun
benefit
equilibrium
state
dynam
model
ignor
period
chang
start
intervent
reach
equilibrium
diseas
preval
may
fluctuat
extrem
import
econom
evalu
posit
time
prefer
sinc
initi
period
closer
time
intervent
henc
cost
benefit
accru
period
influenti
reason
techniqu
ideal
use
construct
populationspecif
transmiss
dynam
model
restrict
data
limit
even
wide
rang
possibl
scenario
key
paramet
govern
differ
popul
model
consid
also
sophist
approxim
could
use
simpli
appli
equilibrium
state
dynam
model
start
intervent
exampl
one
method
approxim
herd
immun
propos
retain
cohort
structur
take
account
gradual
reduct
forc
infect
postvaccin
equilibrium
reach
figur
flow
diagram
algorithm
key
question
need
ask
choos
differ
type
model
investig
infecti
diseas
intervent
section
provid
brief
descript
featur
infecti
diseas
natur
histori
relev
model
detail
avail
elsewher
mani
stage
infect
diseas
see
figur
b
infect
diseas
begin
exposur
suscept
host
infecti
agent
host
infect
latent
period
begin
follow
infecti
period
individu
infecti
other
length
latent
period
vari
sever
day
influenza
decad
tuberculosi
final
stage
one
host
remov
infect
popul
recoveri
death
differ
stage
diseas
also
commenc
time
infect
first
stage
diseas
incub
period
usual
last
partway
infecti
period
follow
symptomat
period
howev
infect
may
simpli
result
asymptomat
infect
rather
diseas
although
purpos
intervent
ultim
reduc
burden
diseas
rather
infect
transmiss
model
need
take
account
unreport
case
asymptomat
symptomat
contribut
infect
transmiss
henc
affect
consequ
intervent
one
exampl
influenza
pandem
number
case
symptomat
diseas
reduc
widespread
asymptomat
infect
lead
natur
immun
popul
individu
recov
infect
may
develop
natur
immun
epidemiolog
model
attempt
captur
detail
biolog
mechan
immun
respons
instead
make
one
sever
assumpt
natur
immun
illustr
figur
susceptibleinfectioussuscept
si
model
assum
natur
immun
occur
individu
recov
infect
immedi
suscept
infect
kind
simplest
option
may
appropri
repres
diseas
gonorrhoea
confer
immun
usual
caus
pathogen
highli
divers
evolv
rapidli
avoid
immun
defencessusceptibleinfectiousrecov
sir
model
assum
host
infect
individu
lifetim
time
horizon
model
appropri
repres
diseas
measl
natur
immun
close
lifelongsusceptibleinfectiousrecoveredsuscept
sir
model
assum
host
protect
reinfect
time
recov
natur
immun
infect
wane
time
appropri
model
infect
viru
influenza
continu
chang
time
natur
immun
particular
season
strain
lost
yearssusceptibleexposedinfectiousrecov
seir
model
sir
model
modifi
includ
latent
period
individu
infect
transmit
infect
import
infecti
diseas
dynam
sinc
introduc
delay
reduc
speed
epidem
spread
popul
also
repres
phase
host
infecti
without
symptom
may
import
individu
expect
chang
contact
pattern
onset
symptom
note
sei
seir
model
also
possibl
incorpor
latent
period
si
sir
model
way
natur
immun
model
influenc
cost
effect
intervent
intervent
vaccin
infect
largest
effect
henc
cost
effect
model
natur
immun
infect
model
use
si
model
least
effect
use
sir
model
natur
immun
creat
pool
individu
alreadi
resist
infect
henc
anyon
infect
longer
benefit
vaccin
often
choic
model
repres
natur
immun
straightforward
lack
data
exist
persist
natur
immun
parametr
uncertainti
refer
variat
numer
input
valu
decis
analyt
model
paramet
may
includ
transit
rate
health
state
valu
govern
efficaci
intervent
well
cost
util
weight
associ
health
state
parametr
uncertainti
occur
paramet
estim
result
epidemiolog
econom
studi
subject
sampl
error
lack
valid
bia
due
differ
model
actual
studi
popul
probabilist
sensit
analysi
often
consid
best
method
account
uncertainti
joint
distribut
paramet
exampl
requir
econom
evalu
commiss
uk
nation
institut
health
clinic
excel
howev
probabilist
sensit
analysi
particularli
challeng
conduct
infecti
diseas
model
key
paramet
model
includ
contact
rate
differ
individu
eg
individu
differ
age
risk
group
probabl
infect
individu
transmit
infect
suscept
individu
contact
recent
contact
rate
difficult
quantifi
estim
impos
simpl
age
structur
model
fit
contact
rate
data
current
infect
statu
popul
recent
populationbas
contact
survey
measur
contact
rate
relev
airborn
close
contact
infect
directli
howev
subject
sampl
measur
error
still
requir
probabl
transmiss
differ
type
contact
closecontact
airborn
known
henc
uncertainti
contact
rate
transmiss
probabl
need
captur
way
incorpor
related
one
method
take
everi
contact
two
individu
record
survey
sampl
space
draw
random
bootstrap
sampl
space
time
sampl
match
individu
current
infect
statu
survey
thu
obtain
joint
distribut
repres
uncertainti
next
probabl
transmiss
chosen
enabl
model
fit
data
current
infect
statu
popul
structur
uncertainti
refer
differ
choic
health
state
model
relationship
instanc
natur
immun
follow
recoveri
infect
model
use
differ
possibl
structur
si
sir
sir
figur
three
structur
success
fit
outcom
data
appropri
adjust
forc
infect
howev
si
structur
predict
prevent
measur
vaccin
longterm
durat
protect
greatest
impact
cost
effect
sir
structur
predict
least
impact
one
way
deal
structur
uncertainti
parameter
rang
choic
averag
outcom
structur
paramet
vari
case
natur
immun
durat
natur
immun
could
consid
paramet
vari
plausibl
rang
rang
could
potenti
take
valu
zero
lifetim
individu
si
model
correspond
valu
zero
sir
valu
infin
sir
intermedi
valu
henc
mani
form
structur
uncertainti
reduc
parametr
uncertainti
howev
practic
mani
model
construct
parameter
plausibl
model
choic
fit
understand
diseas
model
consequ
usual
techniqu
account
parametr
uncertainti
may
underestim
uncertainti
model
uncertainti
refer
variat
aris
result
differ
categor
choic
readili
parameter
instanc
brisson
edmund
discuss
seri
model
varicella
vaccin
involv
sever
model
choic
choic
static
dynam
model
ii
choic
model
exposur
person
infect
varicella
reduc
individu
risk
zoster
anoth
diseas
caus
reactiv
viru
previous
infect
individu
one
without
effect
neither
choic
reliabl
parameter
first
decis
use
either
simplifi
model
complex
potenti
realist
one
base
consider
discuss
articl
second
depend
model
belief
hypothesi
epidemiolog
evid
mean
complet
accept
case
may
appropri
weight
differ
model
choic
use
model
averag
rang
choic
methodolog
uncertainti
refer
variat
aris
result
differ
choic
model
valu
due
norm
issu
rather
result
difficulti
reflect
object
realiti
consider
includ
appropri
discount
rate
appli
type
econom
analysi
cost
effect
cost
benefit
time
horizon
analyt
perspect
use
choic
often
made
base
refer
case
decisionmak
bodi
adopt
reflect
societ
prefer
issu
time
prefer
equiti
tradeoff
differ
sector
societi
howev
guidelin
usual
written
noninfecti
diseas
mind
inde
countryspecif
guidelin
econom
evalu
specif
discuss
infecti
diseas
although
australian
guidelin
vaccinespecif
appendix
discuss
need
consid
herd
immun
guid
standard
evalu
vaccin
programm
uniqu
characterist
methodolog
choic
larg
effect
result
econom
evalu
infecti
diseas
intervent
alway
predict
effect
intervent
one
exampl
issu
time
horizon
cost
outcom
assess
lifetim
time
horizon
usual
appropri
evalu
intervent
chronic
noninfecti
diseas
cost
health
benefit
incur
death
recipi
intervent
howev
intervent
vaccin
infecti
diseas
wider
cost
benefit
continu
accru
long
lifetim
person
receiv
inde
infecti
diseas
intervent
caus
perman
chang
pathogen
ecolog
erad
evolut
henc
choic
time
horizon
crucial
difficult
establish
illustr
case
varicella
vaccin
short
time
horizon
caus
vaccin
appear
less
cost
effect
increas
case
zoster
older
unvaccin
adult
result
reduc
immun
boost
contact
peopl
infect
varicella
howev
longer
time
horizon
intervent
becom
increasingli
cost
effect
zoster
incid
decreas
vaccin
cohort
protect
zoster
later
life
apart
time
horizon
intervent
outcom
occur
mani
year
intervent
vaccin
hpv
hepat
b
also
highli
sensit
choic
discount
rate
anoth
exampl
strong
extern
associ
communic
diseas
possibl
infect
individu
spread
infect
other
henc
intervent
vaccin
social
distanc
may
benefit
peopl
individu
receiv
intervent
possibl
net
disbenefit
direct
recipi
furthermor
impact
prevent
mitig
pandem
sar
influenza
hiv
wider
economi
may
consid
decis
maker
import
actual
health
impact
henc
perspect
limit
health
sector
cost
outcom
may
ignor
consid
import
benefit
certain
infecti
diseas
intervent
econom
evalu
infecti
diseas
intervent
like
continu
play
import
role
decis
make
howev
model
conduct
evalu
need
understand
uniqu
featur
diseas
intervent
model
well
appropri
choic
model
use
